Nine in 10 cancer survival rates worse than in Europe
Figures are a result of delays on new drugs, as study warns NHS appears 'uncomfortable with innovation'
Stay updated with breaking news from Life Sciences Vision. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Figures are a result of delays on new drugs, as study warns NHS appears 'uncomfortable with innovation'
Two major medical companies pull out of Britain’s official pricing scheme at a time of soaring demand for treatment
Angie Reynolds, head of Birmingham Research Park, at University of Birmingham Enterprise, explains why lab space is crucial for the support of medical technology innovation.
We have previously noted that 2023 may be a blockbuster year for European biotech deal making. A recent article in the Financial Times examines the…
Time between approval of a clinical trial to first dose of a drug being given to patients in Britain is more than eight months